New York State Common Retirement Fund
RPRX icon

New York State Common Retirement Fund’s Royalty Pharma RPRX Stock Holding History

New York State Common Retirement Fund’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1M Buy
215,522
+15,050
+8% +$783K 0.02% 688
2026
Q1 		$9.62M Buy
200,472
+5,063
+3% +$222K 0.01% 730
2025
Q4 		$7.55M Buy
195,409
+2,178
+1% +$83.1K 0.01% 862
2025
Q3 		$6.82M Sell
193,231
-3,062
-2% -$111K 0.01% 935
2025
Q2 		$7.07M Buy
196,293
+7,000
+4% +$232K 0.01% 912
2025
Q1 		$5.89M Sell
189,293
-77,522
-29% -$2.46M 0.01% 976
2024
Q4 		$6.81M Sell
266,815
-13,500
-5% -$358K 0.01% 965
2024
Q3 		$7.93M Sell
280,315
-47,251
-14% -$1.31M 0.01% 890
2024
Q2 		$8.64M Buy
327,566
+16,251
+5% +$450K 0.01% 880
2024
Q1 		$9.45M Sell
311,315
-78,967
-20% -$2.33M 0.01% 838
2023
Q4 		$11M Sell
390,282
-37,697
-9% -$1.04M 0.02% 780
2023
Q3 		$11.6M Sell
427,979
-58,028
-12% -$1.72M 0.02% 748
2023
Q2 		$14.9M Sell
486,007
-16,880
-3% -$572K 0.02% 700
2023
Q1 		$18.1M Buy
502,887
+4,845
+1% +$180K 0.02% 609
2022
Q4 		$19.7M Buy
498,042
+3,807
+0.8% +$159K 0.03% 569
2022
Q3 		$19.9M Sell
494,235
-23,616
-5% -$1.01M 0.03% 529
2022
Q2 		$21.8M Buy
517,851
+123,850
+31% +$5.08M 0.03% 507
2022
Q1 		$15.3M Buy
394,001
+6,891
+2% +$271K 0.02% 769
2021
Q4 		$15.4M Sell
387,110
-5,571
-1% -$216K 0.02% 795
2021
Q3 		$14.2M Buy
392,681
+19,804
+5% +$770K 0.02% 841
2021
Q2 		$15.3M Buy
372,877
+1,377
+0.4% +$58.6K 0.02% 793
2021
Q1 		$16.2M Buy
371,500
+235,000
+172% +$11.1M 0.02% 734
2020
Q4 		$6.83M Buy
+136,500
New +$5.79M 0.01% 1132

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

New York State Common Retirement Fund's RPRX Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Royalty Pharma (RPRX) stake by 7.5% in Q2 2026, buying an estimated $783K and bringing the position to 215,522 shares worth $12.1M. The position accounts for 0.02% of the portfolio, ranked #688.

New York State Common Retirement Fund first reported a position in RPRX in Q4 2020 and has held it in 23 quarters since. The position peaked at $21.8M in Q2 2022. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • New York State Common Retirement Fund held 215,522 shares of Royalty Pharma worth $12.1M as of Q2 2026.
  • New York State Common Retirement Fund bought 15,050 Royalty Pharma shares in Q2 2026, an estimated $783K.
  • Royalty Pharma made up 0.02% of New York State Common Retirement Fund's portfolio in Q2 2026, its #688 holding.
  • New York State Common Retirement Fund first reported a position in Royalty Pharma in Q4 2020 and has held it in 23 quarters since.
  • New York State Common Retirement Fund's Royalty Pharma position peaked at $21.8M in Q2 2022.
  • 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.